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Integrin signalling triggers cytoskeletal rearrangements, including endocytosis and exocytosis
of integrins and other membrane proteins. In addition to recycling integrins, this trafﬁcking
can also regulate intracellular signalling pathways. Here we describe a role for av integrins in
regulating Toll-like receptor (TLR) signalling by modulating intracellular trafﬁcking. We show
that deletion of av or b3 causes increased B-cell responses to TLR stimulation in vitro, and
av-conditional knockout mice have elevated antibody responses to TLR-ligand-associated
antigens. av regulates TLR signalling by promoting recruitment of the autophagy component
LC3 (microtubule-associated proteins 1 light chain 3) to TLR-containing endosomes, which is
essential for progression from NF-kB to IRF signalling, and ultimately for trafﬁc to lysosomes
where signalling is terminated. Disruption of LC3 recruitment leads to prolonged NF-kB
signalling and increased B-cell proliferation and antibody production. This work identiﬁes
a previously unrecognized role for av and the autophagy components LC3 and atg5 in
regulating TLR signalling and B-cell immunity.
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I
ntegrins are heterodimeric membrane proteins that link
extracellular signals to the cytoskeleton1. av Integrins
comprise the av subunit paired with one of ﬁve different b
subunits, and represent a major family of integrins with
overlapping speciﬁcities and functions2. We and others have
shown that av integrins have critical roles in the immune system
which include promoting lymphocyte migration3,4, internalizing
and presenting microbial and self-derived ligands to innate
immune receptors5–9 and mediating activation of transforming
growth factor (TGF)-b10–13. Many of these functions of av
integrins can be attributed directly to their ability to bind speciﬁc
ligands and mediate cell–matrix or cell–cell interactions. However
av integrins have also been reported to regulate signalling by
other receptor pathways, such as epidermal growth factor and
vascular endothelial growth factor receptors, through less well-
understood mechanisms. Again, these roles of av integrins are
also implicated in the immune system, where avb3 and avb5 can
promote signalling through antigen-speciﬁc and innate immune
receptors8,14, as well as responses to growth factors and
chemokines15. In B cells, these functions of av may support
differentiation of immature cells and promote lymphoma15,16.
This property of av integrins to ﬁne-tune intracellular
signalling pathways led us to investigate their role in B-cell
responses. Activation of B cells is initiated by antigen binding to
diverse, clonally expressed B-cell receptors (BCRs), but full
differentiation into antibody producing cells, requires additional
accessory signals which determine the type and strength of
antibody response. These accessory signals were thought to derive
primarily from T-cell co-stimulation, from additional receptors
recognizing opsonizing complement and antibody, and from the
local cytokine environment. More recently, it has become clear
that B-cell activation is also inﬂuenced by signals associated with
the antigen itself, notably through germline-encoded receptors
for microbial antigens, such as, Toll-like receptors (TLRs)17.
During primary immune responses, these additional signals
augment BCR-derived signals to promote proliferation, class
switching and entry into germinal centres, ensuring the antibody
response is tailored to the source and context of the antigen. In a
number of mature B-cell populations, most notably ‘innate B
cells’ that reside in the marginal zone (MZ) or serosal cavities
(B-1 cells), but also in memory and plasma cells, TLR signalling is
sufﬁcient to stimulate proliferation and antibody production
without strong BCR stimulation18–20, ensuring maintenance of a
long-lived memory pool in the absence of antigen21 and allowing
rapid polyclonal responses to neutralize nascent infections22.
However, TLRs also recognize host-derived components, notably
DNA and RNA (ligands for TLR9 and TLR7, respectively), and
self ligand activation of TLRs is increasingly implicated in
autoreactive cell expansion and autoimmune pathology23–25. This
is particularly apparent in systemic lupus erythematosus (SLE),
where in mouse models, production of characteristic anti-nuclear
autoantibodies is directly dependent on B-cell TLR signalling26.
The potential pathogenic consequences of activation by
self-derived ligands therefore requires BCR and TLR signalling
to be tightly regulated. Identifying the mechanisms by which this
happens is critical for understanding how B cells balance the need
for robust defence against pathogens while preventing excessive
immune responses to self.
Here we describe a cell-intrinsic role for av integrins in
regulation of B-cell signalling. We report that deletion of av from
B cells leads to expansion of transitional and MZ B cells, and
increased antibody responses to self and foreign antigens
associated with TLR ligands, and show that in the absence of
av or its partner b3, B cells respond more strongly to TLR
ligands. Speciﬁcally, we show that av promotes the recruitment of
the autophagy component LC3 (microtubule-associated proteins
1 light chain 3) to TLR-containing endosomes. The effect of this
is two-fold: ﬁrst, LC3 recruitment is required for transition
from NF-kB to interferon regulatory factor 7 (IRF7) signalling;
and second, TLRs trafﬁc from endosomes to a lysosomal
compartment where signalling is terminated. Deletion of av,
LC3b or atg5 lead to prolonged NF-kB and MAPK signalling, and
delayed or absent IRF7 activation, causing increased B-cell
proliferation and antibody production. Taken together these data
identify a new pathway of regulation of B-cell activation that
involves avb3 and autophagy components, and provide mechan-
istic insights into the role of av integrins in regulating immune
signalling.
Results
avb3 is expressed at high levels on activated B cells. Developing
and mature B cells in bone marrow, lymphoid organs and the
peritoneal cavity express surface av integrin, and one of its
partner b subunits, b3, and levels of both integrins are
generally higher in IgMhigh IgDlow B-cell populations than in
IgDhigh IgMlow cells (Fig. 1; Supplementary Fig. 1). IgMhigh cells
included two related populations of cells, MZ and B-1 B cells, and
increased expression of avb3 in these cells was conﬁrmed by
additional ﬂuorescence-activated cell sorting (FACS) analysis
(Supplementary Fig. 1). Lack of suitable antibodies prevented
staining for other av heterodimers by ﬂow cytometry, but
RT-PCR (PCR with reverse transcription) demonstrated that
B cells also express RNA for b1 and b5 (Itgb1 and Itgb5,
respectively) but not b6 and b8 (Supplementary Fig. 1).
B-cell-speciﬁc av-knockout mice were generated (by crossing
Itgavﬂox/ﬂox (ref. 10) and Cd19-Cre mice27). These mice, referred
to here as av-CD19 mice, showed speciﬁc and efﬁcient deletion
of av integrins in B cells (described previously in ref. 10 and
Supplementary Fig. 1). Early B-cell development appeared largely
normal, which is expected as the CD19-Cre transgene does not
delete efﬁciently until late in development, and mature
populations of B cells were present in lymph organs and bone
marrow of adult mice. However, av deletion affected transitional,
MZ and B-1 cells, and frequencies of all three were increased in
spleens of av-CD19 mice. Similar increases in transitional cells
were seen in b3 / mice, and both transitional and MZ B cells
were increased in b3 / b5 / double knockout mice. We
therefore concluded that avb3, and to a lesser extent avb5,
contribute to MZ and B-1 B-cell numbers in the spleen. av-CD19
mice also exhibited an increase in B-1 cells in the blood but had
decreased numbers in the peritoneal cavity (Fig. 1c). This
apparent discrepancy between spleen and peritoneal B-1 cell
effects may be explained by increased activation of these cells; in
the spleen, this would be expected to cause expansion of cells and
re-localization within the spleen, whereas activation of peritoneal
B-1 cells causes their exit to the intestine and other sites.
Increased TLR responses in av-deﬁcient B cells. To investigate the
role of av further, subpopulations of primary B cells were sorted
from av-CD19 and control mice, and stimulated in
culture. MZ and B-1 cells showed little response to BCR
crosslinking, with no difference between control and av-deﬁcient
cells (Fig. 2a). However, when stimulated with TLR ligands, MZ
and B-1 cells proliferated robustly, and this was signiﬁcantly
increased in av-deﬁcient cells compared with controls, regardless of
the TLR ligand used (Fig. 2a). This was particularly pronounced for
responses to TLR9-stimulating CpG oligonucleotides (CpG), to
which all cells in the culture proliferated and was due to TLR
signalling as no proliferation was seen in response to the non-TLR
ligand control oligonucleotide GpC (Fig. 2b). av-deﬁcient cells also
produced signiﬁcantly more IgM and IgG after stimulation through
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TLRs (Fig. 2c). Similar increases in proliferation were seen in
b3 / MZ B cells stimulated through TLRs, whereas b5 / B
cells proliferated normally (Fig. 2d).
Deletion of av, b3 or b5 had no effect on proliferation of
follicular B cells stimulated through crosslinking of the BCR
or through the co-stimulatory molecule CD40 (Fig. 2e),
suggesting that these integrins were not promoting general
survival of proliferating cells, but were speciﬁcally affecting
response to TLR stimulation. Naive follicular B cells do not
respond strongly to TLR stimulation, and the low levels of
proliferation seen in response to CpG were unaffected by av
(Fig. 2e). To assess the role of av in TLR response in follicular
cells, we ﬁrst activated them by BCR crosslinking. This allows
these cells to respond strongly to TLR stimulation19 (Fig. 2f) but
does not affect their expression of surface av (Supplementary
Fig. 2). In this activated state, av-deﬁcient cells proliferated
signiﬁcantly more than control cells in response to all TLR
ligands, as we saw for MZ B cells (Fig. 2f).
av Deletion similarly promoted B-cell proliferation in vivo.
Basal proliferation of both MZ and B-1 cells was increased in
av-CD19 mice compared with littermates (as measured by
5-bromo-2-deoxyuridine (BrdU) incorporation; Fig. 2g,h), and in
direct agreement with our in vitro observations, higher
numbers of proliferating MZ and B-1 cells were detected after
injection of mice with CpG (Fig. 2g,h). Proliferation of follicular
B cells, which are not stimulated robustly by TLR ligands, was
unaffected by av deletion. We therefore concluded that av
regulates B-cell responses to stimulation through TLRs, and that
this is mediated by avb3.
Increased antibody responses in av-CD19 mice. We next
analysed antibody responses in av-CD19 mice. Consistent with
the lack of change in total B-cell number in av-CD19 mice, total
serum immunoglobulin levels were similar to those in control
mice (Supplementary Fig. 3). However, av-CD19 mice had 5–10
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Figure 1 | avb3 is upregulated in MZ and B-1 cells. (a) Surface expression of av and b3 integrins on spleen and peritoneal B cells. Histograms show
staining for av or b3 (ﬁlled histograms) and isotype control antibody (open histograms) on B cells gated based on IgM and IgD expression as indicated.
(b,c) Increased frequency of MZ and B-1 B cells in av-CD19 mice. (b) Representative FACS analysis of splenocytes, gated on B220þ cells, and showing
regions deﬁning transitional/immature (T/Imm), MZ and follicular (Fo) B cells, and percentages of B220þ cells within each region. Mean frequency±s.d.
from 4 mice per genotype is shown in histograms. (c) Frequency of B-1 cells (B220þ CD21þ CD5þ cells) in spleen, blood and peritoneal cavity of
av-CD19 and control mice. Mean frequency±s.d. from 4 mice per genotype is shown in histograms. (d) Representative FACS analysis of splenocytes from
b3 / , b5 / , b3b5 / and control mice, analysed as in (b). Mean frequency±s.d. from 3 to 7 mice per genotype is shown in histograms. *Po0.05,
student’s t-test. For all data shown, similar results were seen in three independent experiments.
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times higher titres of natural antibody than controls, and
produced more antigen-speciﬁc IgM and IgG3 following
immunization with the T-independent antigen, NP (4-hydroxy-3-
nitrophenyl)-Ficoll, (Fig. 3a,b). Natural and T-independent
responses are mediated by B-1 and MZ B cells, and these data
are therefore consistent with the increased MZ and B-1 cell
proliferation in av-CD19 mice.
As our in vitro studies indicated that av speciﬁcally
regulated TLR signalling in B cells, we immunized mice with
a T-cell-dependent antigen (NP-Chicken gamma globulin
(NP-CG)) using the TLR ligand LPS as an adjuvant, av-CD19
mice produced similar titres of anti-NP IgM and IgG to
control mice (Supplementary Fig. 3), but made signiﬁcantly
higher levels of anti-NP IgG2c isotype antibody (Fig. 3c).
Previous studies of the role of TLR ligands as adjuvants28
have shown that class switching to IgG2 isotypes requires
B-cell-intrinsic TLR signalling29,30. Our data were therefore
consistent with effects on LPS signalling to B cells.
Supporting this, we found that av-CD19 mice mounted normal
antibody responses when immunized using an alternative
adjuvant, alum, which does not act through TLR
signalling, whereas combined alum and LPS again led to
higher levels of IgG2c (Fig. 3d). B-cell-intrinsic TLR signalling
has also been implicated in the production of autoantibodies
to nucleic acids in mouse models of SLE31,32, and anti-
dsDNA (double-stranded DNA) autoantibody titres were
signiﬁcantly higher in av-CD19 mice than littermate controls
(Fig. 3e). Together, therefore, these functional studies
demonstrate that av integrins regulate B-cell proliferation and
antibody production in response to self and foreign antigens
associated with TLR ligands.
av Promotes intracellular TLR9 trafﬁcking. The ability of TLRs
to signal is regulated by their subcellular localization, which
controls both ligand accessibility and the availability of speciﬁc
signalling adaptors33. Signalling through the intracellular TLRs,
such as TLR7 and TLR9, ﬁrst require the TLR and ligand to trafﬁc
to the same endosomal compartment and subsequent signalling
requires additional trafﬁcking events, with NF-kB and IRF7
activation occurring from distinct endosomal compartments34–36.
Likewise, although cell surface TLRs such as TLR4 bind ligands
and signal through NF-kB at the plasma membrane, they must
relocate to endosomal compartments to engage TRIF and
promote IRF activation37,38. Integrins, particularly avb3 and
a5b1, affect signalling through growth factor receptors by
directing their trafﬁcking39,40 and we therefore decided to
follow TLR localization by confocal microscopy to test the
hypothesis that av regulated TLRs through effects on intracellular
trafﬁcking. MZ B cells express a number of TLRs (which was
unaffected by av deletion; Supplementary Fig. 4), but we elected
to focus on TLR9 for which we had a suitable antibody that would
speciﬁcally recognize the endogenous protein (as previously
reported in ref. 41 and conﬁrmed by us in Supplementary Fig. 5).
In both av knockout and control unstimulated cells TLR9
showed some co-localization with markers for recycling and early
endosomes (transferrin receptor (TfR) and early endosome
antigen 1 (EEA1), respectively; Fig. 4a,b) indicating that a small
proportion of TLR9 was present in endosomes with the
remainder likely to be in endoplasmic reticulum and Golgi41–43
or in endo-lysosomes44. Following stimulation with CpG DNA,
TLR9 co-localization with EEA1 and TfR increased in both
control and av-deﬁcient MZ B cells within 10min (Fig. 4c,d). By
90min, TLR9 co-localization with EEA1 and TfR reduced in
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control cells to levels similar to that in unstimulated cells
(Fig. 4e,f). In contrast, in av-deﬁcient cells, TLR9 co-localization
with EEA1 and TfR remained elevated (Fig. 4e–g). Furthermore,
by 2 h TLR9 in control cells had accumulated into large
intracellular compartments (Fig. 4h), whereas in av-deﬁcient
cells, this did not occur (Fig. 4h,i). We therefore concluded that
av regulates re-localization of TLR9 from early endosomes at
later signalling time points (45–120min).
av Promotes co-localization of TLR9 with LC3. At 2 h
after stimulation, TLR9 co-localized with lysosome associated
membrane protein (LAMP2a) (Fig. 5a), consistent with trafﬁck-
ing to lysosomes. This trafﬁcking of TLR9 was reminiscent of the
accumulation of TLR9 in ‘auto-phagosome-like’ structures in B
cells previously reported by Chaturvedi41 and we therefore tested
whether TLR9 co-localized with a component of the autophagy
machinery and marker of auto-phagosomes, LC3. We observed
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regions of TLR9 co-localization with EEA and/or TfR (Hoechst omitted for clarity in these images), and arrowhead in e marks area of TLR9 accumulation in
control cells that is not associated with TfR or EEA. (b,d,f,g) Quantiﬁcation of co-localization between TLR9 and EEA or TfR. Plots show co-localization
values for individual cells and median (b,d,f) or median alone (g), for 420 cells per condition. *Signiﬁcantly different from control, Po0.005, Mann–
Whitney–Wilcoxon test. (h) Sorted MZ B cells from control or av-CD19 mice stained with antibody against TLR9, with or without stimulation with CpG
DNA for 120min. Representative images are from a single confocal section. Arrow indicates re-localization of TLR9 seen in control cells. (i) Quantiﬁcation
of TLR9 re-localization in sorted spleen MZ or peritoneal B-1 B cells. Each data point is based on analysis of at least 30 cells by confocal microscopy. Graph
represents percentage of cells with reorganized TLR9 as seen in 120min control cells in ﬁgure (h). In all cases, similar results were seen in three
independent experiments. Scale bars, 2.50mm.
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that TLR9 co-localized with LC3 in primary MZ and B-1 cells,
initially in small endosome-like structures B45min after
stimulation, and this increased signiﬁcantly as TLR9 became
organized into the larger structures seen 2 h after TLR stimulation
(Fig. 5b). Notably, re-localization of LC3 did not occur in
TLR9 / cells, indicating that TLR signalling initiated this
process (Fig. 5c,d). av was critical for this process, as both
co-localization of LC3 and TLR9, and the formation of large
LC3-positive complexes, were reduced in av-deﬁcient B cells
(Fig. 5e,f).
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Figs 6 and 7.
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Increased and prolonged TLR signalling in av-deﬁcient cells.
Given the critical role of subcellular localization for TLR9
signalling, we predicted that the alterations in trafﬁcking would
be associated with changes in activation of NF-kB and IRF
pathways. In MZ B cells from control mice, phosphorylation of
Ik-B-kinase (IKK) occurred rapidly (within 10min) following
TLR stimulation and returned to near basal levels by 2 h (Fig. 5g).
Likewise, nuclear localization of the p65 component of
NF-kB peaked at 10min and largely subsided by 2 h (Fig. 5h).
In contrast, in av-deﬁcient B cells, the peak levels of both
phosphorylation of IKK and nuclear localization of NF-kB were
increased following TLR stimulation compared with control cells,
and in the case of NF-kB, activation was prolonged and remained
elevated at later time points (Fig. 5g,h; Supplementary Fig. 6).
We also noted that nuclear localization of NF-kB was higher in
av-deﬁcient B cells than in controls even before stimulation,
which is likely to be the cause of the increased basal proliferation
of MZ B cells in av-CD19 mice. The increased and prolonged
activation of NF-kB in av-deﬁcient cells correlated with the
extended association of TLR9 with early endosomes, suggesting
that NF-kB signalling occurred from this compartment, in
agreement with previous reports in myeloid cells36. MAP
kinase (MAPK) signalling is thought to occur from the
same compartment as NF-kB, and supporting this, levels of
phospho-ERK and phospho-MAPK were increased at their peak
and at later time points in av-deﬁcient cells compared with
controls (Supplementary Fig. 6).
IRF7 activation in control B cells occurred later than NF-kB, at
around 45min, and reduced to background levels by 2 h (Fig. 5h).
This is consistent with other studies showing that IRF7 signalling
is triggered from a distinct endosomal compartment, and in our
B-cell system this corresponded with the initial co-localization of
TLR9 and LC3 in small endosome-like structures. In av-deﬁcient
cells, IRF7 activation was signiﬁcantly delayed, occurring at
2 h after TLR stimulation, suggesting to us that av regulates
transition of TLR9 from NF-kB-signalling compartments to
endo-lysosomal compartments competent for IRF7 signalling,
and that this may be mediated by recruitment of LC3. Notably
this role for av in LC3 re-organization and TLR signalling was
not restricted to the TLRs that reside in endosomes, as
av-dependent LC3 re-organization was also seen in MZ and
B-1 B cells after stimulation through TLR4 (Fig. 5i,j).
Likewise, deletion of av also led to prolonged NF-kB signalling
downstream of TLR4 (Fig. 5k).
av is internalized to early endosomes during TLR signalling.
To understand the mechanism by which av-directed trafﬁc of
TLRs, we followed localization of this integrin during stimulation
of B cells. Visualizing av by confocal microscopy, we observed
some co-localization with TLR9, which was most pronounced in
cells stimulated with CpG for 10min (Fig. 6a). However, av did
not localize to the TLR9-LC3-positive lysosomal compartments
seen 2 h after stimulation (Fig. 6a). To gain increased resolution
of av and TLR9 localization in these early time points after TLR
stimulation, we used super-resolution microscopy (STORM)45.
When isolated B-1 B cells were imaged in a single confocal
section though the centre of the cell, we observed that av and
TLR9 co-localized in structures within the cell (Fig. 6b,c).
The greater resolution available with STORM allowed us
to more accurately quantify the degree of co-localization inside
the cell, and revealed that this was highest shortly (10min) after
stimulation with CpG, declining to baseline levels by 2 h
(Fig. 6c,d). To control for possible misalignment of ﬂuorescent
channels, during dSTORM imaging we used ﬂuorescent beads as
ﬁducial markers to align images for co-localization. However, the
larger depth of focus used for wide-ﬁeld dSTORM compared with
confocal imaging meant that false signals could arise from
proteins separated in the Z-plane; to exclude this possibility, we
also used an independent measure of co-localization, proximity
ligation assay (PLA)46. Conﬁrming results from confocal and
STORM microscopy, PLA showed av and TLR9 co-localization
was increased 10min after CpG stimulation, but returned to
control levels by 2 h (Fig. 6e; Supplementary Fig. 8). Also in
agreement with our microscopy analysis, we observed signiﬁcant
TLR9-LC3 co-localization after 2 h (Fig. 6e). Together, these
complementary microscopy and biochemical approaches
demonstrate that av co-localizes with TLR9 transiently, early
after stimulation.
STORM imaging and PLA analysis suggested that av-TLR9
co-localization occurs inside the cell, most likely in endosomes
where TLR9 resides. To determine whether this involved av
internalization, we labelled cell surface integrin with ﬂuorescently
tagged antibody, incubated with CpG DNA, and then measuring
internalized ﬂuorescence. Using this technique, we found that
CpG stimulated av internalization, and that internalized av was
delivered to an acidic vacuole (Fig. 6f; Supplementary Fig. 9).
Although av integrins bind and mediate uptake of a range
of complex self and microbial ligands, and can function as
co-receptors for TLRs, it did not appear that av was serving as
an internalization receptor in this situation, as uptake of
ﬂuorescently labelled CpG DNA was unaffected by av deletion
(Fig. 6g). On the contrary, we observed that internalization of av
was dependent on TLR signalling, and decreased to background
levels in TLR9 knockout B cells (Fig. 6h). We therefore concluded
that TLR signalling promotes internalization of av to early
endosomal compartments where it co-localizes with TLR9.
av Promotes LC3 lipidation through Src-family kinases.
Although av localized with TLR9 early after stimulation, av did
not appear to mobilize with TLR9 into the LC3-positive
compartments seen at 120min (Fig. 6a), raising the question of
how av regulated the co-localization of TLR9 with LC3.
Recruitment of LC3 to membranes requires conversion of
cytosolic LC3 (LC3-I) to a lipidated form (LC3-II). TLR signalling
induced LC3 conversion in MZ B cells, and this correlated in time
with TLR9-LC3 co-localization (Fig. 7a,b). In av-deﬁcient B cells,
LC3 lipidation was reduced and occurred much later than in
control cells (Fig. 7a,b). This reduced LC3 conversion was not due
to a fundamental defect in LC3 processing machinery in
av-knockout cells as processing through the macroautophagy
pathway, induced by rapamycin, was unaffected by loss of av,
suggesting av is required speciﬁcally for LC3 lipidation induced
by TLR9.
Src-family protein tyrosine kinases, in particular Syk, have
been implicated in lipidation and recruitment of LC3 to
phagosomes47,48. Supporting a similar role for these kinases in
TLR-triggered LC3 lipidation, we found that both Src and Syk
were phosphorylated at activatory tyrosine residues following
CpG stimulation of B cells (Fig. 7c). Src and Syk are both known
to mediate intracellular signalling downstream of avb3 (ref. 49)
suggesting this may be the mechanism by which av couples TLR
signalling to LC3 lipidation. To test this, we ﬁrst assessed Src and
Syk phosphorylation in av-knockout cells. Confounding our
experiments, basal phosphorylation of both kinases was higher in
unstimulated av-knockout MZ B cells than in control cells
(Fig. 7c). Similar increased basal activation of Src-family kinases
has been reported in numerous studies in which integrin
signalling is inhibited50, and appears to be due to disruption of
cell adhesion. However, of relevance to this study, stimulation of
av-knockout B cells with TLR ligands caused no increase in Syk
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graph represents quantiﬁcation of CpG internalization (mean±s.d. from one experiment, n¼ 3 replicates; similar results were seen in 3 independent
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phosphorylation and little, if any, increase in Src phosphorylation
over levels in unstimulated cells (Fig. 7c; Supplementary Fig. 11).
These data allowed us to place Syk activation downstream of av,
and suggested that Src activation is partially dependent on av,
consistent with existing models for integrin signalling in which
activated Src binding to the b3 cytoplasmic tail ampliﬁes Src
phosphorylation and triggers activation of Syk51–53.
To test whether Src and Syk activation are required for LC3
conversion and co-localization with TLR9, we treated B cells with
the pan Src-family kinase inhibitor PP2, or the speciﬁc Syk
inhibitor, piceatannol. Neither inhibitor affected LC3-II
generation in response to rapamycin, but both blocked
conversion of LC3 in B cells treated with CpG DNA and led to
prolonged nuclear localization of NF-kB (Fig. 7d; Supplementary
Fig. 11), similar to the results seen in av-deﬁcient cells.
Furthermore, Syk inhibition prevented co-localization of LC3
with TLR9 and the formation of large TLR9-containing vacuoles
after CpG treatment (Fig. 7e). In phagocytes, Syk activates
production of reactive oxygen species (ROS), which is required
for recruitment of LC3 to phagosomes. In MZ B cells, inhibition
of ROS with diphenyleneiodonium (DPI) or the anti-oxidant
N-acetyl-L-cysteine (NAC) inhibited TLR9-induced LC3
lipidation (Fig. 7f), suggesting that Syk may work through similar
mechanisms to recruit LC3 to endosomes. Taken together, these
data demonstrate that av directs co-localization of TLR9 and LC3
by facilitating the lipidation of LC3 through a mechanism
involving Syk and Src-family kinases.
Loss of LC3 or atg5 increase B-cell TLR signalling. To
determine whether LC3 recruitment is required for the regulation
of TLR signalling by av, we analysed responses of B cells from
mice deﬁcient in one member of the LC3/atg8 family, LC3b. In
LC3b / B cells, TLR9 did not re-localize to large vacuolar
structures following CpG treatment (Fig. 8a), indicating that LC3
itself is required for this aggregation of TLR9. MZ B cells from
LC3b / mice had increased proliferative responses to TLR
ligands, as we saw for av-deﬁcient cells (Fig. 8b). However, unlike
our results with av-CD19 mice, we saw no activation of IRF7 in
LC3b / B cells (Fig. 8c). To conﬁrm that these effects were due
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Fig. 10 and additional quantiﬁcation of western blot analysis is in Supplementary Fig. 11.
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to loss of LC3 lipidation machinery, we also assessed B cells from
mice with B-cell-speciﬁc deletion of the autophagy regulator Atg5
(Atg5-CD19 mice), which functions upstream of LC3 (ref. 54).
For B-cell subsets that are not regulated by av, such as
freshly isolated peritoneal B-2 B cells, atg5-deﬁcient cells
showed reduced proliferation compared with control cells
(Supplementary Fig. 13), consistent with previously reported
roles for atg5 in B-cell survival55–57, which are thought to be due
to loss of macroautophagy. Proliferation of B-1 B cells in response
to BCR crosslinking, which is not regulated by av, was also
impaired in atg5-CD19 mice (Fig. 8d), consistent with the
reported defect in B-1 cell survival in these mice55. However, in
agreement with our observations in LC3b-deﬁcient cells,
proliferation of atg5-deﬁcient MZ and B-1 B cells in response
to TLR stimulation was increased compared with controls
(Fig. 8d). Activation of MAPK, IKK and NF-kB following
TLR stimulation was also increased in atg5-deﬁcient B cells
(Supplementary Fig. 13) whereas, nuclear localization of IRF7
was completely blocked (Fig. 8e). These data therefore conﬁrm
that atg5 and LC3b regulate TLR signalling through NF-kB
and MAPKs, and affect B-cell activation, in similar ways to av
integrins. They also show that LC3 recruitment to TLR
endosomes is absolutely required for IRF7 signalling. Together,
these ﬁndings strongly support a model in which avb3-mediated
activation of regulation of TLR responses occurs through
activation of autophagy components and their association with
TLRs (Supplementary Fig. 14).
Discussion
Our data describe a new mechanism of regulation of B-cell
activation by TLR ligands, mediated by the integrin avb3.
We show that av promotes the trafﬁcking and maturation of
TLR-containing endosomes, and through this mechanism,
reduces polyclonal activation of B cells through TLRs. In mice,
loss of this mechanism by deletion of av from B cells leads to
greater production of natural antibodies and increased responses
to TLR-ligand-associated antigens, but also promotes production
of autoantibodies. We therefore propose that this mechanism
serves to maintain the balance between protective immunity to
microbes and potentially pathological responses to self.
Our data reveal a link between avb3 signalling and two
components of the autophagy pathway, LC3 and atg5, and
identify two key functions for these autophagy components in
TLR signalling. First, we show that av, LC3 and atg5 reduce
cellular response to TLR stimulation, and in the absence of any of
these genes, B-cell proliferation in response to TLR ligands is
greatly increased. Second, we also show that LC3 recruitment to
TLR-containing endosomes is required for IRF7 signalling in
response to TLR ligands. Based on our microscopy and
biochemical data, we propose that TLR9 transitions through
three endolyosomal compartments in B cells during signalling.
Initially, TLR9 engages CpG DNA in an early endosome, marked
by EEA1 and TfR, and signals through NF-kB. TLR9 then
transitions to an LC3-positive endosomal compartment, in a
process triggered by avb3-mediated LC3 lipidation. It is likely
that activation of IRF7 occurs from this LC3þ endosomal
structure, as IRF7 activation coincides in time with the initial
lipidation of LC3 and association with TLR9 while TLR9 remains
distributed throughout the cell, at around 45min in control cells.
TLR9 subsequently trafﬁcs to a much larger vacuolar structure,
which stains intensely for LC3. At this time (2 h after
stimulation), signalling through both NF-kB and IRF7 has
ceased, and this therefore appears to represent a terminal point
in TLR signalling. As this structure also contains LAMP-2, which
is critical for fusion of phagosomes and auto-phagosomes with
lysosomes, we predict that LC3 and other autophagy components
cause termination of signalling by recruitment of lysosomal or
proteasomal machinery, similar to their function in classical or
selective autophagy, although this remains to be demonstrated. In
the absence of av-mediated, LC3-directed trafﬁcking, TLR9
spends longer in early endosomes, leading to prolonged NF-kB
signalling and delayed IRF7 activation, and we conclude that this
is the cause for the increased cell proliferation and antibody
production that we see in av-knockout B cells. Our observation
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*Signiﬁcantly different Po0.05, Student’s t-test. Full western blots are
shown in Supplementary Fig. 12. Unst, unstimulated.
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that av regulates LC3 localization, NF-kB signalling and cell
proliferation in response to the TLR4 ligand LPS strongly
support a similar role for av in signalling by TLRs that engage
their ligands at the cell surface. However, although previous
studies have described how the early progression of
TLR-containing endosomes can affect the nature of the signal,
our data emphasize that the duration of TLR in any compartment
is a determinant of the strength of signalling triggered therein
and reveal a hitherto unappreciated function of autophagy
components in terminating signalling.
The model that we propose based on our data is different from
that originally proposed for TLR9 signalling in pDCs, where IRF7
signalling was thought to originate from early endosomes and
NF-kB signalling required transition to the lysosome34,35. These
original studies were based primarily on the use of different CpG
DNA ligands, which preferentially localized to endosomal or
lysosomal compartments. More recent studies focusing on
responses following alteration of intracellular trafﬁcking and
endosomal sorting are more consistent with our results, namely
that NF-kB signalling occurs from early endosomes and that
these require further maturation to become competent for IRF7
signalling36,58. Notably, recent work identiﬁed LC3 as a critical
component of phagosomes that can signal through IRF7, in direct
agreement with our work59. In addition, our interpretation is
consistent with the model originally proposed for TLR4
(refs 37,38), in which signalling through NF-kB and IRF
pathways occur sequentially and requires transition of the TLR
from the surface to endo-lysosomal compartments. However, it
remains to be demonstrated whether the pathway we described in
B cells functions in other immune cells.
Despite their initial identiﬁcation in the context of autophagy,
it is now apparent LC3, atg5 and related components are
involved in a much broader range of membrane trafﬁcking and
re-organization events in cells. Notably, these, along with atg7,
are intimately involved in internalization of microbial and
self-derived particles, a process termed ‘LC3-associated
phagocytosis’60. The process of av-regulated LC3 activation and
involvement in endocytic trafﬁcking that we have identiﬁed has
several parallels with LC3-associated phagocytosis. First, they
appear to use similar mechanisms as LC3 recruitment to
phagosomes also requires Syk and ROS47,48. Furthermore, LC3
is required for TLR9 signalling through IRF signalling in both
cases (Fig. 8)59. Our data signiﬁcantly extend these roles for LC3
and autophagy components in TLR signalling, demonstrating that
their involvement in vesicular trafﬁc and TLR signalling is not
limited to phagosomes, and identifying an important role in
limiting TLR signalling. Furthermore, our ﬁnding that deletion of
a single LC3/atg8 homologue, LC3b, disrupts this mechanism
raise the possibility that speciﬁc components of this pathway are
specialized for roles in immune signalling.
TLR9 recruitment to auto-phagosome-like compartments has
previously been reported in B cells41. In that study, engagement
of the BCR was required to drive TLR recruitment. In contrast,
our data suggest that TLR trafﬁcking occurs independently of the
BCR and instead requires av. Although seemingly at odds with
our observations, an important difference in the subset of B cells
studied must be considered. The previous study of Chaturvedi
et al. used total spleen B cells, the majority of which will be
un-activated follicular B cells; in contrast, we show that the
av-mediated mechanism occurs only in MZ, B-1 and activated B
cells. Curiously, the Syk-dependent pathway of integrin signalling
implicated in our study shares many components with BCR
signalling53 and it is interesting to speculate that following
activation, avb3 may functionally substitute for the BCR in
regulating TLR localization and signalling in B cells. Our data
show that this switch to av-mediated regulation in activated B
cells is associated with increased surface expression of avb3;
however it is possible that additional changes in signalling
components must also occur to enable this mechanism,
such as immunoreceptor tyrosine-based activation motif
(ITAM)-containing adaptors that can link avb3 to Syk
signalling49,53, and have been implicated in inhibition of TLR
signalling. In other cell systems, Syk interaction requires avb3
ligand occupancy49, and whether speciﬁc ligand engagement
and/or activation of avb3 are also required for integrin-mediated
Src and Syk activation in activated B cells remains to be
determined. Furthermore, it will be interesting to determine how
closely this mechanism of avb3-mediated inhibition of TLR
signalling relates to that reported for integrin aMb2 (ref. 61).
Our ﬁndings support an emerging paradigm in which integrins
affect diverse cellular processes by directing endosomal
trafﬁcking39,40. Of particular relevance to our results, avb3 has
been shown to regulate growth factor signalling by altering the
trafﬁcking of receptors between recycling endosomes, where they
can continue to signal, or the lysosome, where they are degraded.
We ﬁnd that av plays an analogous role is directing the
movement of TLRs from early endosomes to LC3-associated
compartments, and that this is associated both with a transition
from NF-kB to IRF7 activation and with termination of
signalling. Therefore, we propose that although in some settings
av can mediate internalization of ligands, a more important role
is in directing subsequent intracellular trafﬁcking events.
These ﬁndings explain how av-mediated phagocytosis promotes
trafﬁcking of internalized material for degradation and antigen
presentation in previous studies62,63. Intriguingly, in both of these
cases other receptors could compensate for loss of av to mediate
phagocytic uptake, whereas the role of av in directing the
intracellular fate of phagocytic cargo was non-redundant. Taken
together with our data, it therefore becomes possible to formally
dissociate receptors involved solely in internalization of ligands
from those such as avb3 that also regulate intracellular
trafﬁcking.
In summary, our data reveal a novel role for avb3 and
atg5/LC3 in regulating TLR signalling in B cells. Polymorphisms
in atg5 have recently been linked with SLE64,65, raising the
possibility that disruption of the regulatory mechanism we
describe may contribute to autoimmunity in human disease. In
support of this idea, we ﬁnd that loss of this regulatory
mechanism leads to activation of potentially autoreactive
MZ and B1 cells and increased production of antibodies to
self-antigens, although we do not see evidence that av-CD19
mice develop full autoimmunity. We therefore propose that
this mechanism of avb3-regulated, LC3-directed trafﬁcking helps
to maintain the balance between rapid production of broad
speciﬁcity, low afﬁnity antibodies from MZ and B-1 B cells
early in infections while preventing potential development of
high afﬁnity autoantibodies. An important conclusion from this
study is to identify integrin signalling in B cells as a previously
unappreciated mechanism of immune regulation. Extrapolating
from these ﬁndings, we suggest avb3 as a potential new target
for therapeutic interventions—blocking avb3 signalling would be
predicted to augment beneﬁcial vaccine-induced responses
whereas avb3 agonists might limit detrimental self-directed
antibody production.
Methods
Mice. av-CD19 mice were generated as previously described10 and maintained on
a mixed C57Bl/6/ 129Ola background. Littermates with a single CD19-Cre allele
and Itgav-ﬂox alleles were used as controls. As the background strains of these
mice differ at their Igh-1 loci, and in their ability to make IgG2a versus IgG2c82,
for immunization experiments mice were matched by Igh-1 genotype (all were
Igh-1 a/b). The following mouse strains have been previously described and were
used in this study on the following genetic backgrounds: Atg5-CD19 (ref. 64),
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TLR9 / (ref. 66) and GFP-LC3 (ref. 67) (all C57BL/6), LC3B / (ref. 68),
Integrin b3 / (ref. 69) and b5 / (ref. 70; all mixed C57BL/6/129). All mice
were housed under speciﬁc pathogen free conditions at Benaroya Research
Institute, Massachusetts General Hospital, Massachusetts Institute of Technology
and University College London.
Animal experiments were performed under licences from the Institutional
Animal Care and Use Committees of Massachusetts Institute of Technology,
Massachusetts General Hospital and Benaroya Research Institute, within local
and national guidelines for animal care.
Antibodies and reagents. Anti-mouse CD21-APC (7G6), anti-mouseCD23-PE
(B3B4), anti-mouseB220-PE-Cy7(RA3-6B2), anti-mouseB220-APC(RA3-6B2),
anti-mouseCD11b-PE(M1/70), anti-mouse IgM-PE(R6-60.2), anti-mouse
IgD-FITC(11-26c.2a), anti-mouse CD2-FITC(RM2-5) anti-mouse
CD19-APC(1D3), anti-mouse CD71(C2)-biotin, anti-integrin av (RMV-7)-biotin
and Mouse BD Fc block (2.4G2) were from BD bioscience. Anti-TLR9 (26C593.2)
was from IMGENEX. Anti-Calnexin (ab22595), anti-EEA1 (ab50313) and
anti-Lamp2a (ab18528) were from Abcam. Goat anti-rabbit IgG (Hþ L) Alexa
Fluor 546, Streptavidin Alexa Fluor-647, antibody to Src phosphorylated at Tyr 418
and Annexin v alexa ﬂuor 488 were from Invitrogen Molecular probes. Hoechst
33342 was from Immunochemistry. Type C -CpG-ODN 2395, GpC-control
ODN 2395, Type B CpG ODN 1826 and Imiquimod were from Invivogen.
Antibody to ERK phosphorylated at Thr202 and Tyr 204 (20G11); antibody to p38
phosphorylated at Thr180 and Tyr182 (12F8), antibody to Syk phosphorylated at
Tyr (525/526) antibody to IKKa-IKKb phosphorylated at Ser176 and Ser180
(16A6), anti-NFkappa-B (D14E12), anti-Syk, anti-Src, anti-LSD1 (C69G12) and
horseradish peroxidase conjugated anti-rabbit IgG were from Cell Signaling
Technology. Anti-MyD88 (3244-100) was from Biovision. Anti-LC3B, anti-b-actin
(AC-15), propidium iodide, 5-Bromo-20-deoxyuridine, LPS (from E. coli O55:B5),
Rapamycin from Streptomyces hygrsocopicus, DPI chloride and NAC were from
Sigma-Aldrich. Alkaline phosphatase-conjugated anti-mouse IgG-AP, alkaline
phosphatase-conjugated anti-mouse IgM-AP and anti-mouse IgG(Hþ L) were
from Southern Biotech. CFSE (5 and 6 carboxyﬂuorescein diacetate succinimidyl
ester)-(5)(6)-CFDA-SE was from Molecular probes. Thymidine methyl
[3H]-Thymidine was from Perkin Elmer. Afﬁnity puriﬁed F(ab’)2 fragment goat
anti-mouse IgM m chain speciﬁc was from Jackson Immuno Research. Anti-mouse
atto-488 was from (Hypermol, EK, Germany).
Flow cytometry and cell sorting. Cells were harvested in phosphate-buffered
saline (PBS)/0.5% bovine serum albumin (BSA)/2mM EDTA and splenocytes or
bone marrow cells depleted of red blood cells (RBC lysis buffer, Sigma-Aldrich).
Single cell suspensions were blocked with Fc Block (BD Biosciences) and stained
with ﬂuorochrome tagged antibodies for surface markers (1: 200 dilution) at 4 C
for 30min. Samples were acquired using FACSCalibur (BD Biosciences) and
analysed by FlowJo software (Tree Star Inc.). For sorting of spleen MZ and
follicular cells, cells enriched by lympholyte gradient (LympholyteM, Cedar Lane)
were labelled with anti-B220-PE-CY7, anti-CD23-PE and anti-CD21-APC
antibodies then sorted with SORPVantageSE Diva (BD Bioscience). For sorting of
peritoneal B-1 and B-2 cells, peritoneal cavity cells were labelled with anti-B220-
APC, anti-C11b-PE antibodies and sorted as above. For CpG uptake assay, sorted
MZ cells were rested and stimulated with 1 mM CpG Alexa Fluor-647 on ice or
37 C for 30min. Cells were then washed three times in ice-cold PBS followed by
one wash in cold acid wash buffer (PBS with 0.2M acetic acid and 0.5M NaCl) for
5min to remove CpG bound on surface, and analysed by FACS. For integrin
internalization assay sorted MZ cells were labelled with integrin av-FITC
(Hma5-1, EBioscience4) antibody on ice for 30min and assayed as described in
Supplementary Fig. 9. Surface bound antibody was then allowed to internalize for
different times points with or without CpG stimulation at 37 C in regular growth
medium. At each time point cells were washed with cold PBS and remaining
antibody at surface was removed by two acid washes for 2min on ice. Cells were
re-suspended in PBS/0.5% triton to neutralize intracellular vacuoles and recover
quenched internalized ﬂuorescence, and analysed by FACS.
In vitro proliferation assays. Sorted cells were plated in X-VIVO15 (Lonza)
supplemented with 2mM glutamine, 100Uml 1 penicillin and 100mgml 1
streptomycin, and 50mM 2-b-mercaptoethanol or complete RPMI-1640 (10% fetal
bovine serum 2mM glutamine, 100Uml 1 penicillin and 100mgml 1 streptomy-
cin, and 50mM 2-b-mercaptoethanol) at a density of 3 104 cells per well on 96-well
plate and treated with different stimuli: LPS (1mgml 1), CpG or control GpC (1.5 or
3mM), Imiquimod (10mM), anti-IgM F(ab0)2 (10mgml 1) and anti-CD40
(10mgml 1). After 48 h cells were pulsed with 1mCi/well [3H]-Thymidine for 18 h
before harvest; incorporation was determined by liquid scintillation spectrometry. To
measure proliferation by CFSE labelling, sorted cells were stained for 5min at room
temperature with 1mM CFSE, washed with PBS/5% fetal bovine serum and plated as
above. For proliferation of activated follicular cells, FACS-sorted follicular cells were
cultured overnight with or without anti-IgM stimulation (5mgml 1) and washed
extensively before stimulation with TLR ligands as mentioned above.
In vivo proliferation. Mice were injected with 100mg CpG-ODN intraperitoneally
(for analysis of peritoneal cavity cells) or intravenously (for spleen cells), fed with
bromodeoxyuridine (BrdU) continuously via the drinking water (0.8mgml 1
BrdU Sigma-Aldrich, and 10% sucrose) and killed on day 4. Additional mice were
given BrdU water for the same time without CpG injection. Cells from spleen and
peritoneal cavity were surface stained, then ﬁxed and permeabilized, treated with
DNase, and stained with anti-BrdU FITC (BD Biosciences).
Confocal microscopy. FACS-sorted MZ B cells, or enriched peritoneal B cells were
seeded on to poly-L-lysine coated glass cover slips (BD Bio-coat) in complete RPMI-
1640 and allowed to attach for 1 h at 37 C. Next, cells were stimulated with 3mM
CpG for the indicated times. After stimulation cells were ﬁxed with 4% PFA for
20min at room temperature, permeabilized with saponin (0.2% saponin in PBS,
0.03M sucrose, 1% BSA) for 10min at room temperature. Non-speciﬁc binding in
cells was prevented by incubating for 1 h at room temperature with blocking buffer
(2% goat serum, 1% BSA, 0.1% cold ﬁsh skin gelatin, 0.1% saponin, 0.05% Tween-20
in 0.01M PBS, pH 7.2). Cells were incubated overnight at 4 C with speciﬁc primary
antibodies (TLR9 1:250 dilution, LC3 1:500 dilution, EEA1 and TfR 1:500 dilution)
in dilution buffer (PBS, 0.05% Tween-20, 1% BSA, 0.1% saponin). Cells were washed
three times in dilution buffer (5min each) and incubated in secondary antibodies
(1: 500 dilution) in dilution buffer for 1 h at room temperature. Next, cells were
washed three times in dilution buffer and twice in PBS. Cell nuclei were stained with
Hoechst 33342, and the cover slips were mounted with ProLong Antifade
(Invitrogen). Cells were imaged through a 100 oil objective (aperture 1.4) and
Nikon Ti (Eclipse) inverted microscope with Ultraview Spinning Disc (CSU-X1)
confocal scanner (Perkin Elmer). Images were captured with an Orca-ER Camera
using Volocity (Perkin Elmer). Post acquisition analysis such as contrast adjustment,
deconvolution through iterative restoration and three-dimensional reconstruction
were performed using Volocity software. For quantitative analysis of the co-locali-
zation of TLR9 and LC3 or endosomal markers (EEA1 and TFR) Pearson’s corre-
lation was calculated using Volocity software. Proximity ligation assay was
performed using the Duolink In Situ Red Starter Kit Mouse/Rabbit from Sigma-
Aldrich. Peritoneal B cells were cultured on poly-L-lysine coated coverslips and
stimulated and stained as above for confocal microscopy. The primary antibodies
used were anti-TLR9, anti-av and anti-LC3 and PLA probes anti-rabbit PLUS and
anti-mouse MINUS were used with detection reagent red according to Duolink
protocol. Cells were imaged using confocal microscope as above and ImageJ was
used to quantify PLA signal. For statistical analysis the number of positive foci were
counted in 425 total cells in multiple (410) ﬁelds of view per condition.
STORM imaging. Peritoneal B cells or sorted B1 cells were seeded on to poly-L-
lysine coated chamber slides (Nunc Lab-Tek, ThermoScientiﬁc) stimulated, ﬁxed
and stained as for confocal microscopy using anti-mouse atto-488 (Hypermol,
Bielefeld, Germany) and streptavidin 647 as secondary reagents. Samples were
imaged at room temperature on a dSTORM Diskovery imaging system (Molecular
Devices, Sunnyvale, CA, USA), which consisted of a Leica DMI 6000B microscope,
with 100 objective and a ‘Perfect Focus’ system. Wide-ﬁeld imaging was per-
formed in an extracellular solution containing reducing and oxygen scavengers, as
speciﬁed by dSTORM protocols. The ﬂuorochromes were ﬁrst converted to a dark
state using a 637 nm laser at 140 kW, 561 nm at 150mW, or 488 nm at 150mW
(Spectral Applied Research, Richmond Hill, Ontario, Canada). Once the ﬂuor-
ochromes were converted into a desired density of single molecules per frame, the
laser power was reduced and cells were imaged continuously at 8,000–10,000 frames.
Tetraspeck beads 100 nm (with four, well-separated excitation/emission peaks: 360/
430 nm (blue), 505/515nm (green), 560/580nm (orange) and 660/680nm (dark
red)) (Invitrogen) were used as ﬁducial markers to align images. Beads were
adsorbed on the coverslip with the cells, and were in the same ﬁeld of view as cells
during image acquisition. The microscope stand (LEICA DMI6000) was equipped
with hardware autofocusing and continuous focusing, which kept the sample in
focus and at least one bead was in the ﬁeld of view during image acquisition for each
ﬂuorescence channel. dSTORM images were captured at a focal point midway
through the cell. Localization was acquired using a Photometrics Evolve 512 512
backthinned EM-CCD with 16 micron pixels and analysed with MetaMorph
Imaging Software, MetaSeries version 7.8.2 (Molecular Devices, Sunnyvale, CA,
USA) using a 10ms exposure time. Images were reconstructed and analysed in
real-time using the integrated WaveTracer. The WaveTracer module was used to
determine co-localization by examining overlapping pixel signals from each ﬂuor-
escence channel in the reconstructed image. Co-localization analysis was restricted to
intracellular regions of the cell (determined by exclusion of the ‘rim’ of strong av
staining which marks the plasma membrane).
ELISA. Immulon 2HB microtitre plates (DYNEX) were coated and dried overnight
at 37 C with salmon sperm DNA (100mgml 1 in TE buffer). DNA was nitro-
cellulose ﬁltered for dsDNA or heated for 5min at 100 C for ssDNA. After blocking
for 60min at 37 C (2% BSA, 2% fetal calf serum, 0.1% Tween-20 and 0.02% sodium
azide in PBS) sera diluted 1:100 in 50% block were applied (60–120min at 37 C)
followed by alkaline phosphatase-conjugated goat anti-mouse IgM or IgG (Southern
Biotech) diluted in blocking buffer for 60min at 37 C. Secondary antibodies were
detected by using disodium p-nitrophenyl phosphate substrate (Sigma-Aldrich) and
absorbance (OD) read at 405 nm. For detection of total Ig in culture supernatants or
sera plates were coated with 10mg/ml goat anti-mouse IgG (heavy and light chain
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speciﬁc; Southern biotech) in PBS at 4 C overnight. Plates were blocked with 1%
BSA in PBS and incubated with various dilutions of serum sample or cell
culture supernatants in PBS. After incubation with 1:1,000 diluted alkaline
phosphatase-conjugated IgM, IgG, IgG1 or IgG2c (Southern Biotech) colour was
developed as above with disodium p-nitrophenyl phosphate substrate.
Western blots. Cells were lysed for 30min on ice in RIPA buffer containing 1%
NP-40, 0.5% sodium deoxycholate, 0.1% SDS supplemented with sodium
orthovanadate and protease inhibitor cocktail. Nuclear extracts were prepared by
lysing cells in hypotonic nuclear extraction buffer (1M Hepes, PH7.5, 5M NaCl,
0.5M EDTA PH8, 50% glycerol, 10% Igepal and 10% TritonX100) for 10min
followed by centrifugation at 1,500g for 5min at 4 C to pellet the nuclei and nuclei
were re-suspended in RIPA buffer. Lysates were centrifuged for 10min at 4 C at
14,000g and supernatant was collected as nuclear fraction. Proteins were quantiﬁed
by BCA assay (Pierce), separated by electrophoresis using NuPage-Bis-Tris gels
(Invitrogen) and blotted onto PVDF membranes. Non-speciﬁc binding was
blocked with 5% BSA in TBS-Tween (0.1%) followed by incubation with primary
antibodies (1:1,000 dilution) overnight at 4 C and secondary antibody horseradish
peroxidase conjugated antibodies (1:2,000 dilution) for 1 h at room temperature.
Membranes were washed thoroughly with TBS-Tween (0.1%) after antibody
incubations and developed using ECL reagents (Millipore). For re-probing blots
were stripped for 30min at 37 C with Restore PLUS stripping buffer (Thermo
Scientiﬁc). For experiments with inhibitors cells were pre-treated with PP2 (1 mM),
Piceatannol (25 mM), DPI (25 mM) and NAC (5mM) for 30min and cells were
stimulated and processed in RIPA or nuclear lysis buffer as above.
Immunizations. For T-independent immune responses, mice were immunized i.p.
with NP-haptenated Ficoll in PBS at the doses indicated in ﬁgures. For experiments
using TLR ligands and alum as adjuvants, mice were immunized i.p with
NP-CG (Biosearch technologies) 50 mg per mouse in combination with alum
(1:1 suspension) or LPS (5mg per mouse).
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